- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05187013
Uncontrolled Hypertension Among the Homeless
mHealth to Address Uncontrolled Hypertension Among Hypertensive Homeless Adults
This study is designed to assess the effect of implementing a mobile health (mHealth) strategy using text messaging for hypertension (HTN) management among hypertensive homeless persons with uncontrolled blood pressure age 21 or older in shelter-clinics in New York City (NYC). The study uses a randomized clinical trial design (homeless, n=120) and semi-structured interviews (homeless, n=30; providers, n=20).
The control group will receive text messages for usual standard care/healthy lifestyle during a 6-month follow-up period. The intervention group will receive text messages geared towards both standard care/healthy lifestyle and blood pressure control. At the end of study period, the investigators will assess changes in blood pressure (BP) measurements, adherence to clinic visits, and adherence to medication, and the investigators will compare them between the two groups. Qualitative interviews with both patients and providers who provide services to the homeless in shelter settings will develop a better understand barriers and opportunities regarding BP control. The investigators hypothesize that those individuals randomized to the intervention will experience a reduction in blood pressure (8mmHg systolic BP or diastolic BP) and will exhibit better adherence to blood pressure medications and appointments compared to the control group.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Project Renewal operates several urban shelters in five boroughs of NYC. Enrollment, data collection, and retention will be supported at these sites.
Patient participants will be recruited in clinics via medical record reviews and will be randomly assigned to treatment groups using a computer-assisted permuted randomization schedule with a block size of four, stratified by clinic site, severe mental illness, and active substance use disorder. Provider participants are physicians, nurse practitioners, social workers, and counselors working at Project Renewal.
The intervention will include 6 months of mHealth HTN management support via short message service (SMS) texts including reminders for medication adherence, appointment attendance, and HTN-specific health education and support. Texts will be delivered to support medication adherence and lifestyle changes, and participants will receive appointment reminders before each appointments. The control group will receive 6 months of mHealth including basic healthcare and general health promotion via SMS texts on the same schedule as the intervention group. Both groups will undergo BP measurements and adherence assessments at appointments in the shelter-clinics. All texts will be interactive and reciprocal; during the study, feedback to SMS texts, including automated and reciprocal feedback for patient-specific input, will be directly provided to patients to enhance education and behavioral changes.
Primary outcome measures will be recorded at 0, 2, 4, and 6 months, and secondary outcome measures will be collected throughout the study. Qualitative interviews with persons experiencing homelessness with HTN (n=30, 15 each arm) and providers (n=20) will be conducted at the end of the recruitment period. Trained research assistants (RA) will collect data and perform the semi-structured interviews.
During clinic visits, BP will be measured by trained clinic nurses in a seated upright position on the right arm with a properly sized cuff. Two readings will be taken at 2-minute intervals following 5 minutes of rest and will be averaged and recorded. Proportion of days covered (PDC) and pill counts will be conducted at each visit. Additional information, including appointment attendance, will be collected from the medical record.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
District of Columbia
-
Washington D.C., District of Columbia, United States, 20052
- George Washington University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Currently experiencing homelessness
- Current diagnosis of hypertension
- SBP above 140mmHg or DBP above 90mmHg at most recent clinic visit
- English or Spanish speaking
- Currently presenting to Project Renewal shelter-clinics for medical care
- Connected to multidisciplinary social and health services at Project Renewal
Exclusion Criteria:
- Pregnant or within 3 months post-partum
- Heart attack or stroke within previous 6 months
- History of aortic aneurysm
- Diagnosis of end-stage renal disease or currently on dialysis
- Inability to read or respond to SMS texts
- Any condition preventing participants from providing informed consent
- SBP >175mmHg or DBP >105mmHg unless medical provider determines patient has no symptoms suggesting a hypertensive emergency or urgency
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Hypertension-Specific Education
6 months of mHealth HTN management support via SMS texts including reminders for medication adherence, appointment attendance, and HTN-specific health education and support.
Texts will be delivered to support medication adherence and lifestyle changes, and participants will receive appointment reminders before each appointments with a follow-up text and robocall if the appointment is missed.
|
SMS text messages sent to participants' mobile phones
|
|
Other: General Health Education
6 months of mHealth including basic healthcare and general health promotion via SMS texts.
Blood pressure measurements and adherence assessments will be collected at every shelter visit.
|
SMS text messages sent to participants' mobile phones
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood Pressure
Time Frame: 6 months
|
Systolic and diastolic blood pressure readings (SBP and DBP)
|
6 months
|
|
Medication Adherence
Time Frame: Overall over 6 months
|
Medication adherence was measured using the Voils 3-Item DOSE-Nonadherence measure, a 5-item Likert scale.
This was measured by dichotomizing the response options such that any score of 2-5 on any of the three Extent of Non-adherence items is considered non-adherent (e.g., code as 1), and a response of 1 (none of the time) on all items is considered adherent (e.g., code as 0).
The extent of adherence was then reported as a median percentage of the total participants with an IQR range as reflected below.
|
Overall over 6 months
|
|
Appointment Attendance
Time Frame: 6 months
|
Percentage of appointments attended
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants Who Completed Interviews
Time Frame: 6 months
|
The number of interviews that were completed concerning participants' experiences. All data obtained are qualitative. |
6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Ramin Asgary, MD, MPH, George Washington University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NCR203140
- 1R21MD016201-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
Clinical Trials on mHealth for Hypertension in Homeless Persons
-
George Washington UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Not yet recruiting
-
University of Massachusetts, WorcesterNational Cancer Institute (NCI); Institute of Population, Health and Development...Enrolling by invitationTobacco CessationVietnam, United States
-
Yale UniversityUniversity Health Network, Toronto; Fogarty International Center of the National... and other collaboratorsCompleted
-
McGill UniversityNot yet recruiting
-
Bangladesh University of Health SciencesBangladesh University of ProfessionalsEnrolling by invitationCardiovascular Diseases | HypertensionBangladesh
-
Infectious Diseases Research Collaboration, UgandaNot yet recruiting
-
Hospital de SabadellBristol-Myers SquibbUnknownSmoking | Hypertension | Diabetes Mellitus | Peripheral Arterial Disease | HypercholesterolemiaSpain
-
Trisakti UniversityCompletedUpper Respiratory Tract InfectionIndonesia
-
Indiana UniversityWithdrawnArthritis, Rheumatoid | Vitamin D DeficiencyUnited States